Prusila, Roosa Enni Inkeri <br/><br/>
Treatment of diffuse large B-cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP-16).  [electronic resource] 

 -  Hematological oncology  Apr 2019 
 - 136-142 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1099-1069 
<br/><br/><label>Standard No.: </label>10.1002/hon.2572  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Drug Substitution<br/>Epirubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Heart Diseases--chemically induced<br/>Humans<br/>Kaplan-Meier Estimate<br/>Lymphoma, Large B-Cell, Diffuse--drug therapy<br/>Male<br/>Matched-Pair Analysis<br/>Prednisone--administration & dosage<br/>Progression-Free Survival<br/>Retrospective Studies<br/>Rituximab--administration & dosage<br/>Vincristine--administration & dosage